SAFETY POLICIES FOR CREUTZFELDT-JAKOB DISEASE
AND UNDIAGNOSED ENCEPHALITIS CASES.
GUIDELINES FOR HIGH RISK
OR POTENTIALLY HIGH-RISK
AUTOPSY CASES.
DRAFT COPY ONLY.
(Procedure 213).
http://www.netautopsy.org/axsop/axsop213.htm
NEXT PAGE
PREVIOUS PAGE
RETURN TO TABLE OF CONTENTS
United States Government Work, uncopyrighted, public-domain,
DRAFT COPY ONLY. This document does not necessarily represent the views
or policies of any United States Government agency.
This document is provided "as is", without warranty of any kind,
express or implied, including but not limited to the warranties
of merchantability, fitness for a particular purpose and
non-infringement. In no event shall the authors be liable
for any claim, damages or other liability, whether in an
action of contract, tort or otherwise, arising from, out of,
or in connection with the document or the use or other dealings
made with the document.
See also: Infection Control Policies:
036, 136,
216, 217.
PRINCIPLE OF THE TEST.
Proper cautionary measures are necessary in the prevention
of exposure to Creutzfeldt-Jakob disease.
SPECIMEN REQUIRED.
At the Veterans Affairs Medical Health Care System (VAMHCS),
autopsies are performed on deceased patients with a valid
Authorization for Autopsy
(U. S. Standard Form 523), a complete hospital chart,
and a death note signed by a physician included in the chart.
REAGENTS, INSTRUMENTATION.
Protective garments. Formic acid (see below).
STEP-BY-STEP DESCRIPTION.
SAFETY POLICIES FOR CREUTZFELDT-JAKOB DISEASE
AND UNDIAGNOSED ENCEPHALITIS CASES.
by Oscar A. Iseri, M.D.
INTRODUCTION. Creutzfeldt-Jakob disease (CJD)
is a fatal dementing disorder of humans.
1. Clinical diagnosis is based upon a history of rapidly
progressive dementia, presence of myoclonic movements, and
a characteristic electroencephalogram.
2. Diagnostic overlap with Alzheimer's disease and other
atypical dementing diseases.
3. At autopsy, most patients with classic Creutzfeldt-Jakob
disease show some spongiform change in brain tissue.
4. Creutzfeldt-Jakob disease are characterized by presence
of prion protein (PrP), which is probably the infective agent.
5. Incubation period may be from months to decades, but once
symptoms develop, the disorder is usually fatal within one year.
6. CJD is apparently not spontaneously contagious,
but there have been instances of iatrogenic transmission,
e.g., corneal transplants from a diseased patient.
7. CJD has been reported in histology technicians and in
a pathologist, but epidemiologic studies have repeatedly
failed to demonstrate an excess incidence of CJD in
health care workers or in autopsy room personnel.
8. There is a possible risk of transmission of CJD
from Bovine Spongiform Encephalopathy,
reported in Great Britain.
Since CJD can only be confirmed at autopsy, further study
of CJD from autopsy materials is important.
9. The CJD agent is killed by steam-autoclaving at 136 degrees
Celsius for one hour. Disinfectants such as 10% bleach and
2N sodium hydroxide have been claimed to disinfect the agent,
but there is evidence that they may not.
10. The following procedures use the 10% bleach solution,
which is at least partially effective, but which is more
convenient to use among the two.
PROCEDURE.
1. Personnel should be limited to the Prosector
and Autopsy Assistant.
2. Attire includes double long-sleeved surgical gowns,
double surgical gloves, wire-mesh gloves are advisable,
Air-Mate Hepa system powered air-purifying personal
respirator, goggles, waterproof apron, and shoe covers.
3. The room is prepared with appropriate surgical
instruments and cleared of all unnecessary items in order to
minimize surface exposure.
4. The room entrance is provided with a bleach-soaked foot
mat (10% bleach).
5. The cadaver is transferred to the autopsy room
in a plastic body bag and placed on the autopsy table.
6. The upper body is uncovered. Blood is obtained by
intracardiac puncture and transferred to vacutainers
for centrifugation. Serum is removed with a syringe
to cryogenic vials, sealed, and placed in -70 degrees Celsius
storage.
7. With only the head uncovered, cerebrospinal fluid (CSF)
is obtained by propping the head forward, flexed toward the
chest, and inserting a long-shaft needle immediately beneath
the occipital region penetrating into the basal
cerebellomedullary cistern (cisterna magna). The CSF
is collected and transferred to cryogenic vials which
are stored in a -70 degrees Celsius freezer.
8. The skin of the scalp is incised and reflected in the
usual manner. The skull is carefully opened with a Stryker Saw,
WHILE SURROUNDED BY A TRANSPARENT PLASTIC ENCLOSURE.
IT IS ADVISABLE TO USE A WET TOWEL OVER THE SAW TO TRAP BONE
DUST AND DEBRIS. CARE IS TAKEN TO AVOID CUTTING THE BRAIN
TISSUE WITH THE SAW. THE SKULL CAP IS THEN CAREFULLY REMOVED
TO PREVENT INJURY TO THE FINGERS OF PERSONNEL AND TO KEEP
TISSUES AS STERILE AS POSSIBLE.
THE BRAIN IS REMOVED BY STERILE SCALPEL,
PLACED IN A STERILE STAINLESS STEEL PAN, AND WEIGHED.
With the brain removed, the skull cap is reinstated and the scalp sutured.
Depending upon clinical and/or research needs, the brain is either fixed
in 20% buffered formalin or frozen. THE BRAIN CONTAINER IS SELECTED
TO MAXIMIZE CONTAINMENT OF THE TISSUE.
9. The remainder of the autopsy is conducted in a modified
routine manner: An organ-by-organ, in-situ examination with
tissue sampling but without organ removal is recommended.
10. Decontamination of the exposed body surfaces of the
body is carried out by sponging with 10% bleach. The body
bag is carefully closed, sponged with bleach, and transported
directly to the mortician's vehicle on a sterile cart.
(It is advised that the cadaver be cremated rather than
conventionally buried.)
11. Decontamination of the autopsy room involves flushing
of all work surfaces and floor surfaces with 10% bleach and
the autoclaving of all surgical instruments.
12. Disposable items are collected and placed in a plastic
bag, sealed, and incinerated.
13. The Stryker saw is sponged with bleach.
14. Instruments are immersed in water and autoclaved
at 132 degrees Celsius for one hour.
15. All washing fluids and other liquids are ultimately
placed in a stoppered sink with greater than four volumes
of bleach added to the final waste volume. After one hour,
the sink is drained of its contents.
16. Following the decontamination procedure, the gown,
mask, shoe covers, and goggles are removed and placed
in double plastic bags and sealed for incineration. Finally,
the gloves are removed to a red BIOHAZARD plastic bag
for incineration. Call Environmental Management (ext 6662)
to arrange for immediate pickup.
17. The prosector and Autopsy Assistant exit the room
by walking on the bleach-soaked mat.
TISSUE PROCESSING.
18. All tissue preparations are carried out in a laminar
flow hood, if available. All working materials are gathered
and placed within the hood prior to tissue handling.
Wear cap, gown, mask, goggles, and gloves. The use of
disposable utensils is strongly advised.
19. The infected tissue is placed in a plastic Petri dish.
A small portion of tissue is removed to a wax block. Thin
tissue blocks are placed into labeled cassettes, which are
then placed in a jar with 20% buffered phenol-formalin
and transported to the processing area.
20. The hood is then decontaminated. All disposable items
are placed in double plastic bags and incinerated, including
clothing and gloves. Other utensils are autoclaved
at 136 degrees Celsius for one hour or soaked for one hour
in bleach.
21. All tissue blocks are decontaminated for routine
microtomy by immersion for one hour in 96% formic acid
for one hour, after formalin fixation and before routine
processing.
22. The infected tissue may be processed through
an automatic processor. However, the fluids in the processor
must be added to four volumes of bleach before discarding,
the liquid paraffin is incinerated, and the processor
containers are removed and soaked in bleach. The processor
itself is sponged with bleach after use.
23. The infiltrated tissue is transferred to a preheated
mold containing uncontaminated liquid paraffin. The cassette
mold is then snapped into place, and additional paraffin
is applied. The cassette is containerized and placed
in a designated refrigerator to solidify. Once the paraffin
has cooled, the mold is removed and soaked in bleach
or autoclaved.
24. The microtome should be in an isolated area, surrounded
by absorbent material. Disposable razor blades are used to
cut the block. Shavings are collected and containerized
as they are produced. Flotation of sections and mounting are
as usual. Paraffin blocks are resealed by reinstating into
the cassette mold and filling the mold with liquid paraffin.
Blocks are then stored at room temperature.
25. Staining is performed outside the hood, but separate
from routine work. After use, solutions are containerized
and incinerated.
26. General decontamination involves the placement of all
disposable items into double plastic bags, which are then
incinerated. All work surfaces are sponged with 10% bleach.
STEP-BY-STEP DESCRIPTION.
GUIDELINES FOR HIGH RISK OR POTENTIALLY HIGH-RISK AUTOPSY CASES.
by Jan M Orenstein MD, PhD.
Pathologist. Jan, 1984. pp. 33-34.
High-risk or potentially high-risk cases:
1. Viral hepatitis.
2. Jakob-Creutzfeldt disease.
3. Acquired Immunodeficiency Syndrome.
4. Tuberculosis.
5. Others.
General rules. If any one of these diagnoses has been
seriously entertained by the clinical housestaff or is
suspected during the autopsy dissection, institute the
following precautions:
1. Extraordinary care must be taken to avoid accidental
wounds from contaminated sharp objects.
2. Avoid production of aerosols or droplets. When sawing
is necessary, use a hand saw. If a hand saw is not
available, a Stryker saw can be used, but have an assistant
hold a wet towel over the saw to trap dust.
3. Report all accidents immediately to Employee Health Service,
to the
CHIEF, AUTOPSY PATHOLOGY,
available through the VAMHCS paging operator,
or to the on-call attending anatomic pathologist.
4. Wear during the autopsy (preferably all disposable):
Two pairs of gloves; goggles or glasses;
scrubs (shirt and pants); waterproof apron;
Tyvek hood or HEPA Air-Mate system.
See PROCEDURE 11. AUTOPSY ROOM PROCEDURES.
shoe covering; long-sleeved gown. At the completion
of the autopsy, these items are to be placed in double
plastic bags, sealed, and labeled as to the hazard.
5. Only the prosector, pathology attending, and autopsy
assistant are permitted in the dissecting area.
6. Confine all work to the smallest possible area, do not
walk around the room, do not handle telephone, and do limit
potentially contaminated areas.
7. One person at a time works on the body or block.
Two or more pairs of hands removing organs or dissecting
in close quarters is one of the prime causes of cuts and
puncture wounds.
8. All scalpel blades used at autopsy are disposable.
Have a sufficient number ready at the start and only remove
and change blades after they have been properly sterilized.
9. Wash all cuts or puncture wounds immediately and
vigorously with iodine-based disinfectant soap (e.g.,
Betadine, Chlorox in case of Jakob-Creutzfeldt disease).
10. Take special care with contaminated needles. Do not
bend or sheath needles after use; promptly place
in puncture- resistant container filled with specific
disinfectant (see below).
11. Treat all body fluids (blood, gastrointestinal
contents, CSF, etc.) and tissues as potentially contaminated.
Disinfect outside of all containers with appropriate agent
and clearly label as to hazard, e.g., Jakob-Creutzfeldt
disease, AIDS, hepatitis, etc. Precautions: unsterilized
samples to be transported out of the autopsy room, e.g.,
cultures, chemical analysis, or material to be stored unfixed
in the autopsy room, e.g., serum, are to be placed
in double-containers and clearly labeled.
12. Hands must be washed after removing gowns and gloves.
13. All tissue must be fixed adequately before trimming
and blocking.
SPECIAL PRECAUTIONS WITH THE FOLLOWING CASES:
JAKOB-CREUTZFELDT DISEASE
(N Engl J Med 1977; 297: 1253-1258;
N Engl J Med 1982; 306:1279).
Formalin does NOT kill the agent.
The best inactivating agents are (1) autoclaving for
one hour at 121 degrees Celsius and 15 PSI (method
of choice); (2) 5.25 percent Na hypochlorite (Chlorox,
standard household bleach) used at a concentration of at
least 0.5 percent for at least one hour (corrosive to skin,
mucous membrane, eyes, clothes, and non-stainless steel
instruments). Diagnosis should be considered when evidence
of intellectual deterioration, especially if associated with
myoclonic activity, when no space-occupying lesion has been
demonstrated on the brain. Obey all the general rules, plus:
Do not begin the case without contacting
the
CHIEF, AUTOPSY PATHOLOGY,
available through the VAMHCS paging operator,
or the
ON-CALL ATTENDING ANATOMIC PATHOLOGIST.
a. Limit autopsy to brain and eyes except under
extraordinary situations.
b. Eliminate atomizing potentially contaminated material,
e.g., tissue, body fluids. A hand saw is especially
recommended for cutting bones in these cases. Be especially
careful not to cut brain or spinal cord with saw.
c. Do not use running water.
d. Collect all body fluids and tissue, which are not
to be saved, sterilize external surface of container
and treat with hypochlorite solution (at least 0.5 percent)
for a minimum of two hours, autoclave and discard,
either into the drain for fluid or into 10% formalin,
for tissue, which will be subsequently incinerated.
e. At conclusion of the autopsy, sponge body, table,
and all contaminated surfaces (including floor if necessary)
with 5.25% hypochlorite. Autoclave sponges and mops.
f. Limit instruments used. Soak in 0.5% hypochlorite
for at least one hour before autoclaving. Prolonged soaking
in hypocholorite solution will destroy non-stainless steel
instruments; autoclaving alone may be used.
g. Fix all tissues immediately (brain and spinal cord,
20% formalin, rest 10%). For EM, use glutaraldehyde.
Be sure to sterilize outside of containers and label
with JAKOB-CREUTZFELDT PRECAUTIONS and DO NOT TOUCH,
and store separately.
h. If specimens must be washed (from formalin),
do not use running water; use several changes of fresh water
which then must be sterilized with chlorox before disposal.
i. Place all contaminated gowns, sponges, masks, etc.,
in double Biohazard bags appropriately labeled and autoclave
as recommended, then incinerate. Keep volumes down;
use multiple bags if necessary.
j. Use all above precautions when handling formalin-fixed
tissue, e.g., cutting brain, blocking, etc.
(Remember formalin does not neutralize agent.)
k. If cut or punctured, immediately wash area vigorously
with Chlorox and report incident to Employee Health Service, ext 5026,
and the
CHIEF, AUTOPSY PATHOLOGY,
available through the VAMHCS paging operator,
or to the
ON-CALL ATTENDING ANATOMIC PATHOLOGIST.
l. Notify funeral home director of case and precautions.
m. For further details, See PROCEDURE 13:
SAFETY POLICIES FOR CREUTZFELDT-JAKOB DISEASE.
TUBERCULOSIS.
Formalin does not effectively kill
Mycobacterium. (Formalin does reduce infectivity.)
All exposed individuals must know status of PPD, so that
if PPD is negative, they can be tested for conversion after
possible exposure.
Obey all general rules plus: Contaminated lung must be
infiltrated with formalin and not cut for at least 48 hours.
Storage must always be in a closed container, submerged,
and covered with formalin-soaked towels.
HEPATITIS VIRUS.
Formalin kills the virus. Prime problems are cuts
and puncture wounds. Obey all general rules plus: If skin
is broken by contaminated instrument, wash vigorously
with iodine-based disinfectant and report incident
immediately, to Employee Health Service, ext 5026, to the
CHIEF, AUTOPSY PATHOLOGY,
available through the VAMHCS paging operator,
or to the on-call attending anatomic pathologist.
AIDS (ACQUIRED IMMUNODEFICIENCY SYNDROME).
Complete autopsies will be performed when warranted.
Pregnant personnel should not perform or assist with these
autopsies. Contact CHIEF OF AUTOPSY SERVICE
and CLINICAL PATHOLOGY MICROBIOLOGY LAB CHIEF before commencing autopsy.
Removal of the thymus and, where possible, the eyes, should
be part of the dissection. The disinfectant of choice is
5.25% sodium hypochlorite (standard household bleach)
at a dilution of not greater than 1:10 in water. Autoclaving
can also be used, 45 minutes at temperatures of at least
121 degrees Celsius and pressures of at least 20 PSI
(pounds per square inch). Blood, blood products, excretions,
secretions, and tissues are to be considered infectious,
and direct contact with skin and mucous membranes should be
avoided. Obey all general rules, plus:
1. All contacted surfaces and the outside of the body
are to be washed with a 1:10 dilution of bleach.
2. Body fluids that are not to be saved and contaminated
water should be treated with bleach, at a final dilution
not exceeding 1:10, before disposal down the drain.
3. All tissue is to be fixed in 10% formalin either
for saving or prior to incineration.
4. All reuisable instruments are to be soaked in diluted
bleach for 15-30 minutes and then washed with sterilizing
agents as usual. Alternatively, autoclaving can be used.
5. Place body in plastic cadaver bag, label as
'AIDS PRECAUTIONS', and notify the mortician.
6. Running water can be used to wash formalin-fixed
tissues and organs.
7. If a tuberculous infection is suspected, appropriate
precautions should be instituted.
REFERENCES.
1. Bastian FO, Jennings RA.
Creutzfeldt-Jakob disease. Procedures for handling diagnostic
and research materials.
Infection Control. 1984;5:48-50.
2. Gajdusek DC, Gibbs CJ, Asher DM, et al.
Precautions in medical care of, and in handling materials from,
patients with transmissible virus dementia (Creutzfeldt-Jakob disease).
N Engl J Med. 1977;297:1235-1238.
3. Committee on Health Care Issues,
American Neurological Association.
Precautions in handling tissues, fluids, and other contaminated materials
from patients with documented or suspected Creutzfeldt-Jakob disease.
Ann Neurol. 1986;19:75-77.
4. Tateischi J, Takatoshi T, Tetsuyuki K.
Inactivation of the Creutzfeldt-Jakob disease agent.
Ann Neurol. 1988;24:466.
5. Tami Y, Fumiaki T, Sadanori M.
Inactivation of the Creutzfeldt-Jakob disease agent.
Ann Neurol. 1988;24:466-467.
6. Bell JE, Ironside JW.
How to tackle a possible Creutzfeld-Jakob disease necropsy.
J Clin Pathol. 1993;46:193-197.
7. Miller DC.
Creutzfeldt-Jakob disease in histopathology technicians.
New Engl J Med. 1988;318:853-584.
8. Gorman DG, Benson DF, Vogel DG, Vinters HV.
Creutzfeldt-Jakob disease in a pathologist.
Neurology. 1992;42:463.
9. Jakob-Creutzfeldt disease.
N Engl J Med. 1977; 297: 1253-1258;
N Engl J Med. 1982; 306:1279.
10. Orenstein JM.
Guidelines for high risk or potentially high-risk autopsy cases.
Pathologist. Jan, 1984. pp. 33-34.
11. Steelman VM.
Creutzfeldt-Jakob disease: recommendations for infection control.
Am J Infect Control. 1994 Oct;22(5):312-318.
"Creutzfeldt-Jakob disease, an infectious, progressive, degenerative
neurologic disorder, has a presumably long incubation period but a rapid,
fatal course. Brain tissue at autopsy resembles that seen in spongioform
encephalopathies of other species. Creutzfeldt-Jakob disease is transmitted
by a proteinaceous infectious agent, or `prion'. Epidemiologic patterns
remain uncertain; various studies have reported conflicting risk factors
in different populations, and genetic susceptibility may be involved.
Although natural transmission routes are still unclear, both iatrogenic
and nosocomial transmissions have been identified. Transmission has occurred
through contaminated electrodes, contaminated biologic products
from cadaveric brains, and infected donor tissues, including dura mater
and corneas. Because the prion is difficult to eradicate, stringent
sterilization precautions must be taken with all surgical instruments.
Some tissues and body fluids (e.g., brain, ocular, central nervous system)
from the patient with Creutzfeldt-Jakob disease are highly infectious,
and must be contained or incinerated. Some body fluids, however,
are not considered infectious. Persons with known or suspected
Creutzfeldt-Jakob disease, or with exposure to potential sources
of iatrogenic infection, should not be considered as donors for any tissues
or biologic products. Occupational transmission to health care and pathology
workers is also possible. Therefore, specific preventive measures
are necessary. Many questions remain regarding transmission and risk factors
for Creutzfeldt-Jakob syndrome, and the precautions presented here
must be considered only preliminary."
PMID: 7847639
Show abstract.
12. Duckett S, Stern J.
Origins of the Creutzfeldt and Jakob concept.
J Hist Neurosci. 1999 Apr;8(1):21-34.
"A review of the publications of Hans Creutzfeldt and Alfons Jakob,
pertaining to the concept which bears their name (CJD),
reveals that they described a neuropathological syndrome,
and were opposed to its classification as a neurological disease.
The evidence on which Creutzfeldt and Jakob based their view is reevaluated,
and studies by other workers are cited in which a range of environmental
and genetic factors generated the CJ syndrome, challenging the proposition
that CJD is a disease with a single cause."
PMID: 11624133
Show abstract.
13. FACTSHEET:CREUTZFELDT-JAKOB DISEASE.
Citation: NSW Public Health Bulletin 2001; 12(2): 43.
WHAT IS CREUTZFELDT-JAKOB DISEASE?
"Creutzfeldt-Jakob disease (CJD) is a rare and fatal brain disease in humans.
It is a type of disease known as a transmissible spongiform encephalopathy
(TSE) because it causes characteristic spongy breakdown of the brain and it
can be transmitted. Other animals-such as sheep, cows and cats-can also
develop TSEs.
THE FOUR MAIN TYPES OF CJD. Sporadic (classical) CJD.
"This is the most common form, responsible for 85 per cent of cases.
The cause is unknown. It mainly affects people aged over 50 years.
Familial CJD.
"This is an inherited form of the disease with a younger age of onset.
It causes 10-15 per cent of cases of CJD.
Iatrogenic CJD.
"This occurs through the inadvertent use of infectious material
in medical procedures.
Variant CJD.
"This is a newly-recognised type that was first discovered in 1996
in the United Kingdom. It is caused by the same infectious agent
that causes 'mad cow disease' (BSE or Bovine Spongiform Encephalopathy)
that has affected cattle in the United Kingdom and other parts of Europe.
It is different to sporadic CJD because it usually affects younger people,
who have a longer duration of illness. It also has slightly different
clinical features and can be distinguished from sporadic CJD by postmortem
laboratory examination of brain tissue (that is, after the person has died).
Evidence of the infection can also be found in lymph tissue, such as tonsils.
WHAT CAUSES CJD?
"It is thought that an infectious agent, known as a prion, causes the damage
to the brain. Prions are different to other infectious agents (such as
bacteria and viruses) because they are made from a protein that is normally
present in all cells. It is believed that the prion causes normal cell
proteins to change into abnormal cell proteins, and that these build up
in the brain, causing damage.
"In inherited CJD the genes that tell the body how to make the protein may be
faulty. In iatrogenic CJD the abnormal protein comes from contaminated tissue
or instruments. Variant CJD is thought to occur when the prion is ingested in
contaminated beef or beef products. It is unclear if other risk factors or
predisposing factors are needed to enable the prion to cause disease.
In sporadic CJD no one knows how the abnormal protein arises.
HOW COMMON IS CJD?
"CJD is rare. It occurs worldwide at a rate of 0.5 to 1 case per million
per year. Overall, Australia has about the same case rate as other countries.
Because of the relationship with Bovine Spongiform Encephalopathy, most cases
of variant CJD have occurred in the United Kingdom (a total of 85 cases as of
November 2000). An additional three cases have been reported in France and
one in Ireland. Because CJD can have an incubation period of many years,
it is unclear how many new cases of variant CJD will occur. As of February,
2001, no cases of variant CJD or BSE have been reported in Australia.
WHAT ARE THE SYMPTOMS OF CJD?
"CJD causes progressive symptoms of difficulty with coordination,
muscle jerks and memory loss with eventual dementia. Variant CJD
can also cause mood disturbance and altered sensations. CJD is fatal,
usually within a year of onset of symptoms. At present there is no cure.
Treatments for symptoms such as pain and muscle jerks are very important
in caring for people with CJD.
HOW IS CJD DIAGNOSED?
"A definite diagnosis can only be made by examining brain tissue after death.
There are, however, other tests such as CAT scans, MRI scans, and EEGs,
that can be highly suggestive of the diagnosis and are used to rule out
other diagnoses. People with variant CJD may have the prion protein present
in their tonsils and other tissues.
CAN YOU CATCH CJD?
"In Australia, iatrogenic CJD has been caused by the use of human growth
hormone taken from the pituitary glands of cadavers that are infected
with CJD. Currently, as there is no Bovine Spongiform Encephalopathy
in Australian cattle, no risk is posed by eating Australian beef
or beef products. Beef and beef products from countries
with infected cattle have been banned from import to Australia.
"There is no evidence that sporadic CJD is spread by blood
transfusion. There is a theoretical possibility that variant CJD
could be transmitted by blood transfusion, although this has never been
reported. As a precautionary measure, people who have spent six months
or more in Great Britain between 1980 and 1996 cannot donate blood.
This is because beef and beef products consumed in Great Britain during
this time could have come from cows harbouring BSE infection. Regular
surveillance for BSE in cattle is carried out routinely in Australia.
"There is no evidence that CJD can be transmitted by normal social contact."
Page Owner: NSW Public Health Bulletin. (New South Wales, Australia).
Last Updated : Tuesday, 02-Oct-01 12:57:20
http://www.health.nsw.gov.au/public-health/phb/feb01html/factsheetfeb01.html
14.
Will RG, Matthews WB.
A retrospective study of Creutzfeldt-Jakob disease
in England and Wales, 1970-1979. 1: Clinical features.
J Neurol Neurosurg Psychiatry. 1984;47:134-140.
15.
Hansen LA, Maslish M, Terry RD, Mirra SS.
A neuropathologic subset of Alzheimer's disease
with concomitant Lewy body disease and spongiform change.
Acta Neuropathol. 1989;78:194-291.
16.
Prusiner SB.
Molecular biology of prion diseases.
Science. 1991;252:1515-1522.
17.
Penar PL, Prichard JW.
Jakob-Creutzfeldt diseaes associated with cadaveric dura.
J Neurosurg. 1987;67:149.
18.
Buchanan CR, Preece MA, Milner RDG.
Mortality, neoplasia, and Creutzfeldt-Jakob disease in
patients treated with human pituitary growh hormone
in the United Kingdom.
BMJ. 1991;302:824-828.
19.
Prusiner SB.
Prions and neurodegenerative diseases.
N Engl J Med. 1987;317:1571-1581.
20.
Collinge J, Owen F, Poulter M, Leach M, Crow TJ,
Rossor MN, Hardy J, Mullan MJ, Janota I, Lantos PL.
Prion dementia without characteristic pathology.
Lancet. 1990;336:7-9.
21.
Will RG.
The spongiform encephalopathies.
J Neurol Neurosurg Psychiatry. 1991;54:761-763.
22.
Bell JE, Ironside JW.
Department of Health National Surveillance of Creutzfeldt-Jakob Disease.
Bull R Coll Pathol. 1991;74:9-10.
23. Traub RD, Gajdusek DC, Gibbs CJ jr.
Precautions in autopsies on Creutzfeldt-Jakob disease.
Am J Clin Pathol. 1973;64:287.
24.
American Neurological Association. Committee on Health Care Issues.
Precautions in handling tissues, fluids, and other contaminated materials
from patients with documented or suspected Creutzfeld-Jakob disease.
Ann Neurol. 1986;19:75-77.
25.
Taylor DM.
Phenolized formalin may not inactivate
Creutzfeldt-Jakob disease infectivity.
Neuropathol Appl Neurobiol. 1989;15:585-586.
26. Brown P, Wolff A, Gajdusek DC.
A simple and effective method for inactivating virus infectivity
in formalin-fixed tissue samples from patients with
Creutzfeldt-Jakob disease.
Neurology. 1990;40:887-890.
27. MacArthur S, Jacobson R, Marrero H, et al.
Autopsy removal of the brain in AIDS: a new technique.
Hum Pathol. 1986;17:1296-1297.